Cargando…

Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)

The prototype ORACLE scale based on two simple measures of type 2 airway inflammation (blood eosinophils and F(ENO)) quantifies the excess risk conferred by raised biomarkers that is removed by type-2 anti-inflammatory treatment in trial populations https://bit.ly/3F1gnUl

Detalles Bibliográficos
Autores principales:	Couillard, Simon, Do, William Il Hoon, Beasley, Richard, Hinks, Timothy S.C., Pavord, Ian D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819242/ https://www.ncbi.nlm.nih.gov/pubmed/35141315 http://dx.doi.org/10.1183/23120541.00570-2021

Ejemplares similares

Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
por: Couillard, Simon, et al.
Publicado: (2022)

Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling
por: Couillard, Simon, et al.
Publicado: (2022)

Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies
por: Jabeen, Maisha F., et al.
Publicado: (2022)

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)
por: Howell, Imran, et al.
Publicado: (2023)

Asthma in pregnancy: An update
por: Couillard, Simon, et al.
Publicado: (2020)

Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ (FeNO) framework
por: Couillard, Simon, et al.
Publicado: (2022)

Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

Reply to Lipworth et al.: Don’t Forget about Facilitatory Effects of Corticosteroids on β(2)-Adrenoceptors in Acute Asthma
por: Moran, Angela M., et al.
Publicado: (2020)

The role of interleukin-17 in asthma: a protective response?
por: Hynes, Gareth M., et al.
Publicado: (2020)

Linking a prototype expert system to an ORACLE database
por: Malandain, E, et al.
Publicado: (1989)

Linking a prototype expert system to an Oracle database
por: Malandain, E, et al.
Publicado: (1989)

Oracles in Decentralized Finance: Attack Costs, Profits and Mitigation Measures
por: Aspembitova, Ayana T., et al.
Publicado: (2022)

Assessing the risk of attack in the management of asthma: a review and proposal for revision of the current control-centred paradigm
por: Blakey, John D, et al.
Publicado: (2013)

Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma
por: Beasley, Richard, et al.
Publicado: (2019)

CD8(+) Tc2 cells: underappreciated contributors to severe asthma
por: Hinks, Timothy S.C., et al.
Publicado: (2019)

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing
por: Couillard, Simon, et al.
Publicado: (2022)

Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?
por: Brown, Mary Ashley, et al.
Publicado: (2022)

The attack of asthma.
por: Friebele, E
Publicado: (1996)

Oracle essentials: Oracle9i, Oracle8i, and Oracle8
por: Greenwald, Rick, et al.
Publicado: (2001)

A Proposed Revision of the Stepwise Treatment Algorithm in Asthma
por: Beasley, Richard, et al.
Publicado: (2021)

The Oxford Agoraphobic Avoidance Scale
por: Lambe, Sinead, et al.
Publicado: (2023)

Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study
por: Foster, Juliet, et al.
Publicado: (2022)

Oracle: Effective Oracle by Design
por: Kyte, Thomas
Publicado: (2003)

Oracle Essbase & Oracle OLAP: the guide to Oracle's multidimensional solution
por: Schrader, Michael
Publicado: (2010)

From spirometry to spatial omics in pursuit of asthma endotypes
por: Hinks, Timothy S. C.
Publicado: (2022)

Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
por: Beasley, Richard, et al.
Publicado: (2019)

Oracle Database Application Security: With Oracle Internet Directory, Oracle Access Manager, and Oracle Identity Manager
por: Mustafa, Osama
Publicado: (2019)

Oracle SQL tuning with Oracle SQLTXPLAIN
por: Charalambides, Stelios
Publicado: (2013)

Oracle SQL tuning with Oracle SQLTXPLAIN: Oracle database 12c edition
por: Charalambides, Stelios
Publicado: (2017)

Quick start guide to Oracle Fusion development: Oracle JDeveloper and Oracle ADF
por: Ronald, Grant
Publicado: (2011)

Phenotyping the Responses to Systemic Corticosteroids in the Management of Asthma Attacks (PRISMA): protocol for an observational and translational pilot study
por: Celis-Preciado, Carlos Andrés, et al.
Publicado: (2023)

Oracle
por: Corey, Michael J.
Publicado: (1995)

Integration of Oracle and Hadoop: Hybrid databases affordable at scale
por: Canali, L, et al.
Publicado: (2017)

Planet-Scale database and Blockchain for the masses (Talk by Oracle)
por: Hu, Wei
Publicado: (2021)

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma
por: Couillard, Simon, et al.
Publicado: (2021)

Oracle essentials: Oracle Database 11g
por: Greenwald, Rick, et al.
Publicado: (2007)

The Oracle Hacker's Handbook: Hacking and Defending Oracle
por: Litchfield, David
Publicado: (2007)

Oracle essentials: Oracle database 10g
por: Greenwald, Rick, et al.
Publicado: (2004)

Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker‐high and ‐low severe asthma
por: Khalfaoui, Latifa, et al.
Publicado: (2022)

The cloud DBA-Oracle: managing Oracle database in the cloud
por: Jain, Abhinivesh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_f54tn1bcdjsfnph0ondp5824p2